NOT YET RECRUITING
NCT07940361
Ultrashort Echo Time (UTE) MRI for Applicator Reconstruction in Gynaecologic Cancer Brachytherapy
The goal of this clinical study is to learn whether an ultrashort echo time (UTE) MRI scan can show the position of brachytherapy applicators and needles more accurately than standard MRI scans in adults with gynaecologic cancer (cervical, endometrial, or vaginal cancer) who are receiving MRI-guided internal radiotherapy (brachytherapy).
The main questions it aims to answer are:
* Does UTE MRI locate the applicator and needle tips more accurately than standard T2-weighted (T2W) and proton-density-weighted (PDW) MRI, when compared with CT?
* Does UTE MRI show a clearer contrast between the applicator and the surrounding tissue?
Researchers will compare applicator positions reconstructed from UTE, T2W, and PDW MRI with CT taken on the same day as the reference standard. They will also check whether differences in applicator reconstruction change the planned radiation dose, and whether image features (radiomics) from UTE MRI before treatment and before brachytherapy help predict cancer recurrence.
Participants will:
* Receive their usual standard brachytherapy treatment, which is not changed by this study
* Have one additional MRI sequence (UTE, about 8 minutes) added to their standard MRI and CT scans at each brachytherapy planning session, with the applicator in place
* Have an additional UTE sequence added to their routine MRI before treatment and before brachytherapy
* Be followed during routine clinical visits for disease outcomes
Gender: FEMALE
Ages: 18 Years - Any
Cervical Cancer
Endometrium Cancer
Vagina Cancer